In this interview, News Medical speaks to Donovan Quill, Executive Vice President of Growth &
Strategy at AscellaHealth about the recurring challenges met when seeking market access rare disease
therapies.
In this interview, News Medical speaks to Donovan Quill, Executive Vice President of Growth &
Strategy at AscellaHealth about the recurring challenges met when seeking market access rare disease
therapies.